Adverse drug reactions: Keratoacanthoma development after systemic administration with irbesartan/hydrochlorothiaZide.
| Autor: | Tchernev, G., Oliveira, N., Kandathil, L. J., Valchkov, T., Batashki, I. |
|---|---|
| Zdroj: | Medical Review / Meditsinski Pregled; 2022, Vol. 58 Issue 3, p55-58, 4p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|